Pubblicazioni

Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan A Phase 2 Single-Arm Clinical Trial

2019 - JAMA ONCOLOGY

Cremolini, C; Rossini, D; Dell'Aquila, E; Lonardi, S; Conca, E; Del Re, M; Busico, A; Pietrantonio, F; Danesi, R; Aprile, G; Tamburini, E; Barone, C; Masi, G; Pantano, F; Pucci, F; Corsi, Dc; Pella, N; Bergamo, F; Rofi, E; Barbara, C; Falcone, A; Santini, D